Differential effects of glycolipid biosynthesis inhibitors on ceramide- induced cell death in neuroblastoma cells

Journal of Neurochemistry

Volumn 72, Issue 3, 1999, Pages 1040-1049

  Bieberich, Erhard ^a   Freischütz, Bettina ^a   Suzuki, Minoru ^a   Yu, Robert K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell death; Gaucher's disease; Glycolipids; Neuroblastoma cells

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; CERAMIDE; DAUNORUBICIN; ENZYME INHIBITOR; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; MIGLUSTAT; SYNTHETASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; GAUCHER DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID COMPOSITION; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

1-DEOXYNOJIRIMYCIN; ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL DEATH; CELL DIVISION; CERAMIDES; ENZYME INHIBITORS; GAUCHER DISEASE; GLUCOSYLCERAMIDES; GLUCOSYLTRANSFERASES; GLYCOLIPIDS; MICE; MORPHOLINES; NEUROBLASTOMA; RATS; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE; TRIXIS;

EID: 0033005150     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721040.x     Document Type: Article

References (56)

1. Abe A., Radin N. S., Shayman J. A., Wotring L. L., Zipkin R. E., Sivakumar R., Ruggieri J. M., Garson K. G., and Ganem B. (1995) Structural and stereochemical studies of potential inhibitors of glucosylceramide synthase and tumor cell growth. J. Lipid Res. 36, 611-621.
2. Ariga T., Jarvis W. D., and Yu R. K. (1998) Role of sphingolipid-mediated cell death in neurodegenerative diseases. J. Lipid Res. 39, 1-16.
3. Atsumi S., Nosaka C., Iinuma H., and Umezawa K. (1992) Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice. Arch. Biochem. Biophys. 297, 362-367.
4. Ballou L. R., Laulederkind S. J. F., Rosloniec E. F., and Raghow R. (1996) Ceramide signalling and the immune response. Biochim. Biophys. Acta 1301, 273-287.
5. Barletta E., Bremer E. G., and Culp L. A. (1991) Neunte outgrowth in dorsal root neuronal hybrid clones modulated by ganglioside GM1 and disintegrin. Exp. Cell Res. 193, 101-111.
6. 9-mannosidase from human kidney is expressed in COS cells as a Golgi resident type II transmembrane protein. Eur. J. Biochem. 233, 644-649.
7. Bieberich E. and Legler G. (1989) Intracellular activity of lysosomal glucosylceramidase measured with 4-nonylumbelliferyl β-glucoside. Biol. Chem. Hoppe Seyler 370, 809-817.
8. Bieberich E., Freischütz B., Liour S.-S., and Yu R. K. (1998) Regulation of ganglioside metabolism by phosphorylation and dephosphorylation. J. Neurochem. 71, 972-979.
9. Boix J., Llecha N., Yusle V.-J., and Comella J. X. (1997) Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines. Neuropharmacology 36, 811-821.
10. Bose R., Verheij M., Haimovitz-Friedman A., Scotto K., Fuks Z., and Kolesnick R. (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82, 405-415.
11. Brigande J. V., Platt F. M., and Seyfried T. N. (1998) Inhibition of glycosphingolipid biosynthesis does not impair growth or morphogenesis of the postimplantation mouse embryo. J. Neurochem. 70, 871-882.
12. Cohen G. M., Sun X.-M., Snowden R. T., Dinsdale D., and Skiletter D. N. (1992) Key morphological features of apoptosis may occur in the absence of internucleosomal DNA degradation. Biochem. J. 286, 331-334.
13. Dahms N. M. and Schnaar R. L. (1983) Ganglioside composition is regulated during differentiation in the neuroblastoma × glioma hybrid cell line NG108-15. J. Neurosci. 3, 806-807.
14. De Maria R., Lenti L., Malisan F., d'Agostino F., Tomassini B., Zeuner A., Rippo M. R., and Testi R. (1997) Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science 277, 1652-1655.
15. Elbein A. D. (1991) Glycosidase inhibitors: inhibition of N-linked oligosaccharide processing. FASEB J. 5, 3055-3063.
16. Felding-Habermann B., Igarashi Y., Federson B., Park L. S., Radin N. S., Inokuchi J., Strassmann G., Handa K., and Hakomori S. (1990) A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis. Biochemistry 29, 6314-6322.
17. Fenderson B. A., Ostrander G. K., Hausken Z., Radin N. S., and Hakomori S.-I. (1992) A ceramide analogue (PDMP) inhibits glycolipid synthesis in fish embryos. Exp. Cell Res. 198, 362-366.
18. Freischütz B., Tokuda A., Ariga T., Bermudez A. J., and Yu R. K. (1997) Unusual gangliosidosis in emu (Dromaius novaehollandiae). J. Neurochem. 68, 2070-2078.
19. Galadari S., Kishikawa K., Kamibayashi C., Mumby M. C., and Hannun Y. (1998) Purification and characterization of ceramide-activated protein phosphatase. Biochemistry 37, 11232-11238.
20. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
21. Hamanaka S., Asagami C., Suzuki M., Inagaki F., and Suzuki A. (1989) Structure determination of glucosyl β-N-(ω-O-linoleoyl)-acylsphingosine of human epidermis. J. Biochem. (Tokyo) 105, 684-690.
22. Hung W. C. and Chuang L. Y. (1996) Induction of apoptosis by sphingosine-1-phosphate in human hepatoma cells is associated with enhanced expression of bax gene product. Biochem. Biophys. Res. Commun. 229, 11-15.
23. Hwang H.-M., Weng S.-C., Lo S.-K., Yu R. K., and Tsai W.-H. (1996) Neuritogenesis, not receptor expression, of NG108-15 cells can be modulated by monosialoganglioside GM1. Chin. J. Physiol. 39, 211-217.
24. Inokuchi J., Mizutani A., Jimbo M., Usuki S., Yamagishi K., Mochizuki H., Muramoto K., Kobayashi K., Kuroda Y., Iwasaki K., Ohgami Y., and Fujiwara M. (1997) Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by synthetic ceramide analog (L-PDMP). Biochem. Biophys. Res. Commun. 237, 595-600.
25. Itabe H., Yamamoto H., Suzuki M., Kawai Y., Nakagawa Y., Suzuki A., Imanaka T., and Takano T. (1996) Oxidized phosphatidylcholines that modify proteins. J. Biol. Chem. 271, 33208-33217.
26. Jarvis W. D., Kolesnick R. N., Fornari F. A., Traylor R. S., Gewirtz D. A., and Grant S. (1994) Induction of apoptotic DNA damage and cell death by activation of sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91, 73-77.
27. Ji L., Zhang G., Uematsu S., Akahori Y., and Hirabayashi Y. (1995) Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358, 211-214.
28. Li R. and Ladisch S. (1997) Inhibition of endogenous ganglioside synthesis does not block neurite formation by retinoic acid-treated neuroblastoma cells. J. Biol. Chem. 272, 1349-1354.
29. Mansat V., Bettaieb A., Levade T., Laurent G., and Jaffrezou J.-P. (1997) Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. FASEB J. 11, 695-702.
30. Nilsson O. and Svennerholm L. (1982) Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J. Neurochem. 39, 709-718.
31. Obeid L. M. and Hannun Y. A. (1995) Ceramide: a stress signal and mediator of growth suppression and apoptosis. J. Cell. Biochem. 58, 191-198.
32. Oberhammer F., Fritsch G., Schmied M., Pavelka M., Printz D., Purchio T., Lassmann H., and Schulte-Hermann R. (1993) Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J. Cell Sci. 104, 317-326.
33. Ohta H., Sweeney E. A., Masamune A., Yatomi Y., Hakamori S., and Igarashi Y. (1995) Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA-fragmentation occurring during phorbolester induced differentiation. Cancer Res. 55, 691-697.
34. Okada Y., Radin N. S., and Hakomori S. (1988) Phenotypic changes in 3T3 cells associated with the change of sphingolipid synthesis by a ceramide analog, 2-decanoylamino-3-morpholino-I-phenylpropanol (compound RV 538). FEBS Lett. 235, 25-29.
35. Platt F. M., Neises G. R., Dwek R. A., and Butters T. D. (1994) N-Butyldeoxinojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem. 269, 8362-8365.
36. Platt F. M., Neises G. R., Reinkensmeier G., Townsend M. J., Perry V. H., Proia R. L., Winchester B., Dwek R. A., and Butters T. D. (1997) Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science 276, 428-431.
37. Prence E. M., Chaturvedi P., and Newburg D. S. (1996) In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology. J. Neurosci. Res. 43, 365-371.
38. Radin N. S. (1996) Treatment of Gaucher disease with an enzyme inhibitor. Glycoconj. J. 13, 153-157.
39. Rice E. O., Mifflin T. E., Sakallah S., Lee R. E., Sansieri C. A., and Barranger J. A. (1996) Gaucher disease: studies of phenotype, molecular diagnosis and treatment. Clin. Genet. 49, 111-118.
40. Rosenwald A. G. and Pagano R. E. (1994) Effects of the glycosphingolipid synthesis inhibitor, PDMP, on lysosomes in cultured cells. J. Lipid Res. 35, 1232-1240.
41. Rosenwald A. G., Machamer C. E., and Pagano R. E. (1992) Effects of a sphingolipid synthesis inhibitor on membrane transport through the secretory pathway. Biochemistry 31, 3581-3590.
42. Schwarz A., Rapaport E., Hirschberg K., and Futerman A. H. (1995) A regulatory role for sphingolipids in neuronal growth. Inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching. J. Biol. Chem. 270, 10990-10998.
43. Sheela-Rani C. S., Abe A., Chang Y., Rosenzweig N., Saltiel A. R., Radin N. S., and Shayman J. A. (1995) Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. J. Biol. Chem. 270, 2859-2867.
44. 3H]-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis, and the synergistic action of an inhibitor of microsomal monooxygenase. J. Lipid Res. 32, 713-722.
45. Suzuki Y. (1995) Disorders of sphingolipid activator proteins. Nippon Rinsho 53, 3025-3027.
46. Svennerholm L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol hydrochloric acid method. Biochim. Biophys. Acta 24, 604-611.
47. Svennerholm L. (1964) The gangliosides. J. Lipid Res. 5, 145-154.
48. Uemura K., Sugiyama E., Tamai C., Hara A., Taketomi T., and Radin N. S. (1990) Effect of an inhibitor of glucosylceramide synthesis on cultured rabbit skin fibroblasts. J. Biochem. (Tokyo) 108, 525-530.
49. Uemura K., Sugiyama E., and Taketomi T. (1991) Effects of an inhibitor of glucosylceramide synthase on glycosphingolipid synthesis and neunte outgrowth in murine neuroblastoma cell lines. J. Biol. Chem. 110, 96-102.
50. Walton K. M. and Schnaar R. L. (1989) Coordinate regulation of ganglioside glycosyltransferases in differentiating NG108-15 neuroblastoma × glioma cells. J. Neurochem. 52, 1537-1544.
51. Wang C.-S. and Smith R. L. (1975) Lowry determination of protein in the presence of Triton X-100. Anal. Biochem. 63, 414-417.
52. Witty J. P., Bridgham J. T., and Johnson A. L. (1996) Induction of apoptotic cell death in hen granulosa cells by ceramide. Endocrinology 137, 5269-5277.
53. Yada Y., Higuchi K., and Imokawa G. (1995) Purification and biochemical characterization of membrane-bound epidermal ceramides form guinea pig skin. J. Biol. Chem. 270, 12677-12684.
54. Yokoyama K., Nojiri H., Suzuki M., Setaka M., Suzuki A., and Nojima S. (1995) Clear differences in ceramide metabolism between glycosphingolipids and sphingomyelin in a human promyelotic leukemia cell line HL-60 stimulated by a differentiation inducer. FEBS Lett. 368, 477-480.
55. Yokoyama K., Suzuki M., Kawashima I., Karasawa K., Nojima S., Enomoto T., Tai T., Suzuki A., and Setaka M. (1997) Changes in composition of newly synthesized sphingolipids of HeLa cells during the cell cycle. Eur. J. Biochem. 249, 450-455.
56. Yu R. K. (1994) Developmental regulation of ganglioside metabolism. Prog. Brain Res. 101, 31-44.